Park Plaza has impressively bucked industry slowdown with maintained like-for-like double-digit RevPAR growth in Q4. Consequently, full-year results (due…
Thales’ full year revenues and order intake aptly demonstrate the dichotomy of defence spending pressures and a buoyant civil aerospace market. With…
In its largest acquisition to date, Brady is purchasing Navita Systems for £17.1m. It is also raising £16.7m (net) through a share placement…
Gasol’s strategy, updated in 2011, is to monetise stranded gas assets in Nigeria and around the Gulf of Guinea and to seek additional routes to optimise…
Allocate substantially solidified its position in H1. It now supplies 45% of all NHS trusts, all of the Australian army and is a market leader in the Australian…
2011 was a year in which Helius reshaped its business, reducing costs and strengthening the balance sheet. 2012 should see a move towards commercial operation…
TiGenix’s stem cell therapy, Cx601, is entering Phase III to treat perianal fistulas. Relapsed or Remicade-unresponsive Crohn’s patients have…
AB Science’s (AB) investment case is dependent on the successful development of masitinib. Impressive Phase II results showing that the tyrosine…
Agennix has stopped the Phase II/III OASIS trial, following the advice of the study Data Safety Monitoring Board (DSMB). It had observed that the 28-day…
MagForce is aiming to raise €4.5m through a shareholder rights issue to support the next phase in commercialising its NanoTherm therapy. NanoTherm…
Sangamo shares gained 21% following the announcement of a significant deal with Shire to research novel approaches to treat haemophilia and other monogenic…
Since the arrival of CEO Philip Kotze on 1 August 2011, Wits Gold has redefined its strategies on exploration and project building to include acquisitions.…
While Amur pursues final approval for its Kun-Manie mining licence with the Russian authorities, recent exploration results achieved over its lease area…
Slater & Gordon (SGH) is poised to enter the UK consumer legal marketplace with an agreement to acquire the prominent and complementary law firm Russell…
Lo-Q has established an attractive niche with its virtual queuing solutions. New product launches broaden the addressable market beyond theme parks and…
Newmark continued to be affected by tough trading conditions in H1 but sees scope for a stronger second half. The long-awaited SATEON has been launched…
Confirmation of near-term purchase orders and service revenues from key customers means that ProMetic Life Sciences has improved visibility on near-term…
Mondo TV made good progress in 2011, operationally and financially, but economic headwinds have prompted management to revise its business plan for 2012-13.…
Walker Greenbank has experienced an amazing year, with progress in all aspects of group operations despite the severe UK consumer trading climate. The…
Avon’s IMS not only shows that the business continues to deliver despite the wider climate, but that the strategy to expand product lines and end…
Given the uncertainty of the investment outlook during the second half of 2011, client activity has been muted in the current period. Mattioli Woods (MTW)…
Matchtech’s H112 trading update outlines very good progress at the Net Fee Income (NFI) level, up 25% over H111, with the headcount increases needed…
Further data from the interim analysis of the Phase III ALSYMPCA study have confirmed Alpharadin’s ability to delay patient development of most skeletal-related…
The last two months have seen Xcite carve out a route to first oil from Bentley in 2012 that can be fully equity funded and without need for FDP approval.…
Dillistone has released an in-line trading update, despite the weak economic backdrop, with bigger than average orders from several customers compensating…
On 27 January, African Barrick (ABG) announced a four-fold increase in resources at its 100% owned Nyanzaga Project (comprising the Tusker and Kilimani…
Orexo’s shares slipped 11% on news that a preclinical stage collaboration with J&J in arachidonic acid research has been terminated. While scrapping…
Scottish Oriental Smaller Companies Trust (SST) has outperformed both its peers and benchmark, more than doubling in the last five years. Its strength…
In its first quarter to end December interim management statement, BD announced good overall trends in assets managed (up from £24 to £24.9bn…
Byotrol’s trading update highlights real progress on new key business projects, overshadowing the short-term impact of revenues running some £1m…
On 20 January SciSys released an in-line trading update in spite of the challenging backdrop. The group has recently announced several contracts that help…
Stobart announced its proposed acquisition of the Moneypenny portfolio for £12.35m on 17 January, as expected after the May 2011 equity fund-raising…
Following a material disposal, the investment proposition is now more clearly growth oriented, although the rating for Fiberweb’s ongoing businesses…
Wynnstay, in our opinion, gives investors an opportunity to benefit from rising global demand for agricultural output, without the risk associated with…
Curis has earned a $10m milestone from Genentech (Roche), following the FDA’s approval yesterday of Erivedge (vismodegib) for advanced inoperable…
SkyePharma’s newly appointed CEO, the former finance chief Peter Grant, should be well placed to negotiate the refinancing of the group’s £83m…
A number of key messages emerge from the interim statement. The first, that new revenue streams are gaining momentum and will compensate for what should…
Red Rock Resources has continued its transition in 2011 away from a holding company function towards an owner-operator one. As such, it begins 2012 with…
Infinity saw a predictable 40% fall in its share price last week after discontinuing saridegib in pancreatic cancer following an adverse result in its…
Quercus’s trading update shows rapid sales growth of both non-Stieg Larsson titles and eBooks. Later than expected promotion for English-language…
KBC’s full-year trading statement confirmed strong ongoing progress in consulting but slippage of a couple of software deals will result in 2011…
Pharmaxis enters 2012 in a promising position after a turbulent 2011. It raised c A$80m in November after the successful reversal, on appeal, of the negative…
2011 was a year of solid trading supplemented by a material business disposal, leaving Powerflute with strong net cash. Clearly the company is in a good…
Augean’s pre-close statement has both reassured and excited us. The core underlying performance is in line with expectations despite the economic…
GB Group today (30 January) released a positive statement for the nine months to 31 December 2011. With the aid of acquisitions (made between June and…
Q3 profit was well up on levels of a year ago and in line with management expectations as Superfos operations and associated synergies continue to feed…
A dynamically designed clinical formulation study of MediGene’s rheumatoid arthritis project, RhuDex, has begun and should yield data around the…
Management warned that recent civil unrest in Nigeria, though good for the economy in the longer term, is likely to result in performance for the full…
Last week’s IMS confirmed further investment, with acquisitions and new construction in Q1. The most recent portfolio valuation (end December 2011)…
Media attention concerning the rare earth group of elements has dragged negative sentiment towards Alkane’s flagship Dubbo Zirconia Project (DZP).…
Netcall’s trading update indicates that the group is on track to achieve consensus growth estimates of 27% EPS growth to 1.9p, resulting in a prospective…
StatPro plans to upgrade all its clients to cloud technology over the next few years. The sales team is accelerating its focus on Revolution while the…
Sirius Minerals has released preliminary core results for hole SM2, targeting the Fordon polyhalite seam at its York Potash Project. Based on the two polyhalite…
New City Energy (NCE) is a fund that invests globally in energy-related equities and fixed interest securities. It focuses on small- and mid-cap companies…
Ebiquity’s strategy of building a worldwide marketing performance management business is reaping benefits, with the group reporting strong FY12 interim…
Zetar delivered a good H112 result with underlying sales growth of 7%. Further progress has been made in laying the groundwork for a much-improved quality…
Efficacy data from the Phase I/II SHELTER study of 4SC’s anticancer agent resminostat strongly back the compound’s potential in the treatment…
Optimal Payments’ (OP) FY11 update confirms trading in line with expectations following strong second half growth and completion of the integration…
A year end update confirmed that FY11results are expected to be up to best estimates. Evidence of business stability in still delicate building products…
We have published a detailed report on Secure Trust Bank (STB), with a product-by-product review of its organic opportunities. This review has led us to…
As a bank with strong capital ratios and excess deposit funding, Secure Trust Bank (STB) is exploiting the vacuum created by the financial crisis in several…
Xaar has announced that all nine staff at its office in China have resigned following a dispute over alleged unfair treatment of staff and Chinese customers.…
Next Fifteen announced in its trading update, released ahead of the company’s AGM, that it has made a solid start to the current financial year.…
Ablynx is increasing its business development activities and focusing resources on the development of four of its clinical programmes. These activities…
Synta has closed a $28.6m (net) underwritten stock offering, extending its cash reach into 2013. The fund-raising comes as Synta is embarking on a significant…
Positive preliminary data with Cogane in an amyotrophic lateral sclerosis (ALS) model should increase confidence in Phytopharm’s strategy to position…
Carador Income Fund (CIFU) has published its monthly report for December. The NAV total return for the month was 0.71% on the US dollar shares and 0.49%…
Goldplat has announced it has poured first gold at its Kilimapesa gold mine in Kenya after successfully commissioning the elution plant that allows Kilimapesa…
Greenwich Loan Income Fund (GLIF) is a closed-ended investment vehicle in the US mid-corporate senior secured debt market. In the past year it has been…
Xaar’s full year trading update flags that strong demand from the ceramics market has once again driven a better than expected sales performance.…
BrainJuicer’s normal seasonality makes Q4 trading crucial to delivering market expectations. Today’s trading update confirms another good Q4…
The Court of Appeal has rejected the challenge of the legal process in Augean’s Environmental Impact Assessment submitted as part of the decision…
The group’s trading update outlines an improved H211 performance and full-year trading broadly aligned to market expectations. We have nevertheless…
An FPSO allows DEO to move towards a hub development structure that aims to lay a foundation for the company and allow it to unlock the potential of the…
In the fourth quarter of 2011, ABG reported the production of 160,020oz of gold to bring its total for the year to 688,278oz. This is in line with guidance…
Valiant offers investors a company with a balanced portfolio of cash flow, exploration and operatorship. With existing production, Valiant is cash producing,…
IQE’s full-year trading update signals that profit will be slightly ahead of downgraded forecasts. Signs of demand stabilisation and positive progress…
In its full-year trading statement, 4imprint reported strong revenue growth continuing into Q411. Group revenue for 2011 rose 10% (13% at constant currency),…
Hambledon (AIM: HMB) has released an operational update for its Sekisovskoye gold mine in Kazakhstan. Of most significance is that initial production from…
Further to the release of drilling results last October, this week Arian released the assay results of an additional 15 holes and an IP survey that we…
In the H1 trading update (13 January) Centaur reported rising EBITDA margins and 4% underlying revenue growth, and confirmed full year profit expectations.…
The Diverse Income Trust (DIVI) was launched in April 2011. It targets stocks with a good and growing income since its manager, Gervais Williams (formerly…
Net trading revenue and PBT (both excluding the discontinued sports operation) confirm earlier guidance of a strong performance. More volatile markets…
Deltex anticipates a transitional 2012 and 2013 as the NHS executive starts to use financial incentives to make modern surgical fluid management a routine…
Transgene is an immunotherapy drug development company that could become a fully-integrated pharmaceutical company over the next five years. After many…
In the full year to December 2011, Cluff reported a 23.3% increase in ore mined, a 7.7% decrease in the stripping ratio and a 6.2% increase in ore processed…
Hybrigenics has already completed recruitment of its Phase II in severe psoriasis with inecalcitol, meaning that it now expects to report the results of…
Cyan has won another initial lighting order in China, which could lead to follow-on orders through 2012. Cyan has more than 40 prospective and active lighting…
Evolva has started 2012 with a deal and could sign a number of others this year. The new alliance is with Roquette to develop a new manufacturing method…
In H211, Photocure implemented a new commercial strategy for its bladder cancer imaging agent Hexvix/Cysview, transforming the potential of its business.…
New technical requirements on new product lines in a ramp-up phase have created manufacturing challenges though these should be bedded down by the year…
Brady has released a healthy trading update this morning, which indicates that FY11 numbers will be slightly ahead of our forecasts, with headline revenue…
Psion’s full-year update indicates sales were slightly weaker than we had forecast, but earnings are in line. Nevertheless, we see the improvement…
Wilex’s rights issue could bring in an extra €10m of cash before costs, providing crucial funds as a bridge to final data from the Phase III…
The completion of the pneumonia data audit and confirmation of the timeline for Basilea’s European data filing of ceftobiprole brings the company…
Avesco is making excellent progress with better than expected FY11 results, a hefty dividend increase and a bumper FY12 in prospect, boosted by the Olympics.…
Positive interim Phase IIb data for Idenix’s lead project, IDX184, should enable the FDA to remove a partial clinical hold, allowing inferferon (IFN)-free…
BioInvent is developing a strong pipeline of four therapeutic antibodies – two in cardiovascular disease and two in cancer. Two are partnered with…
With its pre-close statement Arbuthnot Banking Group (ABG) announced it could not reach agreement on an acceptable structure for a proposed joint venture…
South American Silver intends to enter the ranks of the world’s top silver producers by developing its Malku Khota (100%) silver-indium-gallium project…